supported by the National Natural Science Foundation of China(Nos.32222046,82172630)。
Lymphoma is a hematological malignancy with an increasing mortality rate.Nevertheless,the treatment strategy against lymphoma remains limited.Doxorubicin(DOX)is a broad-spectrum anti-tumor chemotherapeutic drug,the cl...
supported by the National Natural Science Foundation of China(22174042 and 22374038);the Natural Science Foundation for Distinguished Young Scholars of Hunan Province(2021JJ10011);the Postgraduate Scientific Research Innovation Project of Hunan Province(CX20220390)。
DNAzyme-based gene therapy faces some challenges including cell penetration,activity limitation,and co-delivery functions.Self-assembled DNA nanomedicine has attracted widespread attention due to its many advantages.I...